Skip to content
Tuesday, October 13, 2026
PlainHub

Social Media Content Creators Driving Unofficial Market for Unapproved Slimming Medication

An underground market for unapproved slimming drugs is propelled by TikTok fitness influencers and sellers on communication apps, according to recent findings.

Experimental Treatment Gaining Traction Via Social Media

The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged weight-reducing effects. Followers are urged to message these profiles privately for supplier links, while also receiving discount codes.

Active Commerce on Messaging Platforms

Additionally, a flourishing market exists on messaging services, where groups with numerous of participants share “before and after” images, injection guides and assertions of rapid British shipping. Sellers promote the drug there before directing buyers to WhatsApp for transactions.

Learning About The Experimental Drug

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could help individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.

Medical Experts Express Worries

However, physicians and pharmacists have cautions that the sale of what is still an unlicensed drug in the United Kingdom is a cause for concern and could lead to individuals administering substances of unknown origin.

Several experts stated the demand for retatrutide could be linked to the increasing price of approved weight loss products such as Mounjaro.

Regulatory Status and Enforcement

Marketing retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved medication that cannot be promoted or distributed for human use under the British medical regulations.

Some content creators try to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still breach medicines, marketing, and consumer laws, risking fines, prosecution or imprisonment.

Service Reaction and Material Elimination

Based on the social media company, the platform has removed problematic material and prohibited associated keywords and query recommendations. The organization said it was dedicated to maintaining the platform safe and allocating resources in strengthening compliance measures.

Digital Trading Activities

Research also found communities with up to nine thousand members marketing retatrutide using Telegram's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” instantly brings up channels with thousands of users, filled with images of slimming results, glowing testimonials and detailed instructions for mixing or injecting at home.

Within moments of entering one group, a vendor posted contact information, where most transactions take place. The seller sent an guidebook and promised delivery within two days. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None asked about body mass, health issues or previous experience.

Product Details and Pricing

Inside these communities, posts show dark colored packages with postal service stickers, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at residence with sterile water, or ready-to-use injectors typically priced at £160 for 20mg. When asked how much time a pen should last, sellers give conflicting responses ranging from a several days to “depends on your body”.

Service Oversight and Safety Measures

A representative for Telegram said it regularly moderated harmful content on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are administering substances they cannot confirm. Although the science behind this drug is sound, these digital versions may not contain what they advertise,” said Jason Murphy, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the surge in demand to current cost increases for authorized slimming drugs such as Mounjaro. “With prices rising, patients are using online platforms. But counterfeit injections are highly risky. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she explained.

Her staff has previously seen individuals harmed by personal administration from unconfirmed suppliers. “We understand the disappointment, but buying from Telegram or communication platforms is taking chances with your well-being,” said Wyllie. “These materials could be contaminated or improperly measured.”

Producer Statement

A representative from the pharmaceutical company said the substance was in third stage research studies and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a company experimental product not yet approved … may expose users to possibly serious health risks”.

By

Andre Rosales

A software engineer passionate about making technology accessible through clear tutorials and practical advice.

PlainHub

Type to search articles.